Reynolds, Richard J.
Vazquez, Ana I.
Srinivasasainagendra, Vinodh
Klimentidis, Yann C.
Bridges, S. Louis Jr.
Allison, David B.
Singh, Jasvinder A.
Funding for this research was provided by:
National Institutes of Health (K01 AR060848, P30 DK056336, K01 DK095032, R01 DK062148, P50 AR060772, U34 AR062891)
Agency for Healthcare Research and Quality (U19 HS021110)
National Institute on Aging (U01 AG018947)
National Cancer Institute (U10 CA149950)
Article History
Received: 27 April 2015
Accepted: 17 September 2015
First Online: 1 October 2015
Compliance with ethical standards
:
: J.A.S. has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron and Allergan. J.A.S. is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology’s Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. Dr. Allison has received grants, donations, or consulting fees from Pfizer, Arena and Eisai pharmaceuticals.